Adicet Bio to Participate in Upcoming Investor Conferences
Adicet Bio, Inc. announced that its management team will participate in two investor conferences scheduled for November 2026.
Stocks · News reference
Webuy Global shares jumped 15% premarket after H1 revenue nearly doubled to $14.31M and net loss narrowed; Game Your Game led gainers, Masonglory fell.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Adicet Bio, Inc. announced that its management team will participate in two investor conferences scheduled for November 2026.
Wedbush analyst Robert Driscoll maintains Adicet Bio (NASDAQ:ACET) with a Outperform and raises the price target from $25 to $28.
HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $27 to $34.
Firefly Neuroscience announced a strategic focus on its Brain-Computer Interface (BCI) growth, supported by its AI foundation model and the commercial availability of its Versus platform.
U.S. stock futures fell as gold and silver prices slid, sending Gold Fields down 16% and other precious-metal stocks lower in premarket trading.